Physician profile
Brandon E Stewart
NPI 1275295925
$797.35
in general payments reported to CMS, 2019-2025
15 companies · $731 in 2025
The $731 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.46 · 2023: $35.63 · 2024: $15.59 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.73 | 2025 | |
| Madrigal Pharmaceuticals | $182.25 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $141.21 | 2025 | Entyvio, Gattex, Eohilia |
| Qol Medical, LLC | $73.11 | 2025 | Sucraid |
| Astrazeneca Pharmaceuticals LP | $32.88 | 2023-2024 | Andexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.20 | 2025 | Xifaxan |
| Regeneron Healthcare Solutions, INC. | $22.59 | 2025 | Dupixent |
| Tersera Therapeutics LLC | $19.83 | 2025 | Xermelo |
| Csl Behring | $18.34 | 2023 | Kcentra |
| Aimmune Therapeutics, INC. | $17.46 | 2025 | Zenpep |
| Olympus America INC. | $16.77 | 2025 | Single Use Ligating Device |
| Novo Nordisk INC | $16.43 | 2025 | Wegovy |
| Pfizer INC. | $15.46 | 2022 | |
| Genzyme Corporation | $15.29 | 2025 | |
| Phathom Pharmaceuticals, INC. | $13.80 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.